---
title: "Kewaunee Scientific | 10-Q: FY2026 Q2 Revenue: USD 70.1 M"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/269537706.md"
datetime: "2025-12-12T14:43:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/269537706.md)
  - [en](https://longbridge.com/en/news/269537706.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/269537706.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/269537706.md) | [English](https://longbridge.com/en/news/269537706.md)


# Kewaunee Scientific | 10-Q: FY2026 Q2 Revenue: USD 70.1 M

Revenue: As of FY2026 Q2, the actual value is USD 70.1 M.

EPS: As of FY2026 Q2, the actual value is USD 0.82.

EBIT: As of FY2026 Q2, the actual value is USD 5.168 M.

### Domestic Operations

-   **Revenues from External Customers**: $55,224,000 for the three months ended October 31, 2025, compared to $36,409,000 for the same period in 2024.
-   **Earnings Before Income Taxes**: $4,944,000 for the three months ended October 31, 2025, compared to $5,765,000 for the same period in 2024.
-   **Segment Assets**: $150,029,000 as of October 31, 2025.

### International Operations

-   **Revenues from External Customers**: $14,872,000 for the three months ended October 31, 2025, compared to $11,355,000 for the same period in 2024.
-   **Earnings Before Income Taxes**: $1,024,000 for the three months ended October 31, 2025, compared to $610,000 for the same period in 2024.
-   **Segment Assets**: $39,046,000 as of October 31, 2025.

### Corporate/Eliminations

-   **Earnings (Loss) Before Income Taxes**: -$2,515,000 for the three months ended October 31, 2025, compared to -$2,444,000 for the same period in 2024.

### Cash Flow

-   **Net Cash Provided by Operating Activities**: $1,526,000 for the six months ended October 31, 2025, compared to $7,642,000 for the same period in 2024.
-   **Net Cash Used in Investing Activities**: -$2,341,000 for the six months ended October 31, 2025, compared to -$961,000 for the same period in 2024.
-   **Net Cash Used in Financing Activities**: -$2,316,000 for the six months ended October 31, 2025, compared to -$2,886,000 for the same period in 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company remains focused on growth, both organically and inorganically, and is committed to making strategic investments in people, processes, and technology to support sustainable growth. The company is confident that these strategic investments and its healthy backlog position it well to handle any anticipated short-term headwinds and maintain the long-term health of the business.
-   **Non-Core Business**: The acquisition of Nu Aire expands the company’s capabilities, allowing the combined organization to better meet the diverse needs of end-users in laboratory furnishings and accelerates the company’s vision of becoming the market leader in the design and manufacturing of laboratory furniture and technical products essential for outfitting laboratories.

### 相關股票

- [Kewaunee Scientific (KEQU.US)](https://longbridge.com/zh-HK/quote/KEQU.US.md)

## 相關資訊與研究

- [Kewaunee Scientific CFO Donald T. Gardner III Reports Sale of Common Shares](https://longbridge.com/zh-HK/news/271836357.md)
- [Individual investors could get a rare shot at buying into SpaceX from day one](https://longbridge.com/zh-HK/news/281225223.md)
- [16:23 ETNavan, Inc. (NAVN) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/zh-HK/news/281419775.md)
- [17:32 ETCWH Investors Have Opportunity to Lead Camping World Holdings, Inc. Securities Fraud Lawsuit](https://longbridge.com/zh-HK/news/281251488.md)
- [17:52 ETPOM Deadline: POM Investors with Losses in Excess of $100K Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit](https://longbridge.com/zh-HK/news/281081195.md)